We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01690598
First Posted: September 24, 2012
Last Update Posted: June 10, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Abbott
Information provided by (Responsible Party):
Vejle Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)